论文信息 - Convalescent plasma treatment for early post‐kidney transplant acquired COVID‐19

Convalescent plasma treatment for early post‐kidney transplant acquired COVID‐19

Dear Editor, Currently, there are no established treatment protocols for COVID19 that is immediately acquired after kidney transplantation (KTx). To date, the extent and direction of immunosuppression (IS) modifications, as well as addition of anti-SARS-CoV-2 therapeutic agents, is unknown.Here, we describe the successful treatment of three patients with convalescentdonorplasma (CP)whodeveloped severeCOVID-19 directly after receiving KTx.

[1] L. Ren,et al. Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial. , 2020, JAMA.

[2] S. W. Long,et al. Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma , 2020, The American Journal of Pathology.

[3] S. W. Long,et al. Treatment of COVID-19 Patients with Convalescent Plasma , 2020, The American Journal of Pathology.

[4] Victor G. Puelles,et al. Multiorgan and Renal Tropism of SARS-CoV-2 , 2020, The New England journal of medicine.

[5] O. Moerer,et al. COVID-19-associated nephritis: early warning for disease severity and complications? , 2020, The Lancet.

[6] Jing Yuan,et al. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. , 2020, JAMA.